RIVA-PYRANTEL PAMOATE 125 MG
PYRANTEL (PYRANTEL PAMOATE) : 125 MG · DIN 02535467 · LABORATOIRE RIVA INC.
Health Canada status: MARKETED
What is RIVA-PYRANTEL PAMOATE?
RIVA-PYRANTEL PAMOATE 125 MG contains PYRANTEL (PYRANTEL PAMOATE) : 125 MG. It is listed in the Health Canada Drug Product Database under DIN 02535467, held by LABORATOIRE RIVA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 17-Feb-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02535467 |
|---|---|
| Brand name | RIVA-PYRANTEL PAMOATE |
| Generic / active ingredient | PYRANTEL (PYRANTEL PAMOATE) : 125 MG |
| Manufacturer | LABORATOIRE RIVA INC. |
| Strength | 125 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | P02CC01 PYRANTEL |
| AHFS class | 08:08.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 17-Feb-2025 |
| Original market date | 2025-02-17 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code P02CC01 PYRANTEL. 4 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| COMBANTRIN TAB 125MG | 125 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 01944363 |
| JAMP-PYRANTEL PAMOATE | 125 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02380617 |
| JAMP-PYRANTEL PAMOATE SUSPENSION | 50 MG | SUSPENSION | JAMP PHARMA CORPORATION | MARKETED | DIN 02412470 |
| COMBANTRIN ORAL SUSPENSION 50MG/ML | 50 MG | SUSPENSION | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED POST MARKET | DIN 01944355 |
| JAA PYRAL 125 TABLET 125MG | 125 MG | TABLET | JAAPHARM CANADA INC. | DORMANT | DIN 00786055 |
| JAA PYRAL 35 TABLET 35MG | 35 MG | TABLET | JAAPHARM CANADA INC. | DORMANT | DIN 00786047 |
| JAA PYRAL P ORAL PASTE - 125MG/G | 125 MG | PASTE | JAAPHARM CANADA INC. | DORMANT | DIN 02175339 |
| JAA PYRAL S SUSPENSION 50MG/76 | 50 MG | SUSPENSION | JAAPHARM CANADA INC. | DORMANT | DIN 00786063 |
| WORMEDEX | 50 MG | SUSPENSION | LOGAN PHARMACEUTICALS INC. | CANCELLED (UNRETURNED ANNUAL) | DIN 02369974 |
Who else supplies PYRANTEL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PYRANTEL appears in 6 registered pack listings across 4 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.